PURE BIOSCIENCE, INC. (PURE) › Operating Cash FlowPURE BIOSCIENCE, INC. (PURE) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2011: -$6.12M2012: -$5.59M2013: -$3.90M2014: -$6.33M2015: -$6.06M2016: -$4.99M2017: -$4.56M2018: -$3.89M2019: -$2.99M2020: $669.0K2021: -$1.17M2022: -$2.42M2023: -$3.28M2024: -$2.53M2025: -$2.02M-$2.02M2011Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$2.02M+20.4%2024-$2.53M+22.8%2023-$3.28M-35.6%2022-$2.42M-107.2%2021-$1.17M-274.4%2020$669.0K+122.4%2019-$2.99M+23.1%2018-$3.89M+14.8%2017-$4.56M+8.6%2016-$4.99M+17.7%2015-$6.06M+4.2%2014-$6.33M-62.0%2013-$3.90M+30.1%2012-$5.59M+8.8%2011-$6.12M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share